Publisher
Springer Science and Business Media LLC
Reference54 articles.
1. Burcelin, R., Katz, E. B. & Charron, M. J. Molecular and cellular aspects of the glucagon receptor: role in diabetes and metabolism. Diabetes & metabolism 22, 373–396 (1996).
2. Consoli, A. Role of liver in pathophysiology of NIDDM. Diabetes care 15, 430–441 (1992).
3. Jelinek, L. J. et al. Expression cloning and signaling properties of the rat glucagon receptor. Science 259, 1614–1616 (1993).
4. Mu, J. et al. Chronic treatment with a glucagon receptor antagonist lowers glucose and moderately raises circulating glucagon and glucagon-like peptide 1 without severe alpha cell hypertrophy in diet-induced obese mice. Diabetologia 54, 2381–2391, doi:
10.1007/s00125-011-2217-2
(2011).
5. Dunning, B. E. & Gerich, J. E. The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications. Endocrine reviews 28, 253–283, doi:
10.1210/er.2006-0026
(2007).
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献